What does a Hematologist do?

A hematologist deals with the treatment of blood disorders and malignancies, including different types of hemophilia, leukemia, lymphoma, anemia etc.

What are the typical symptoms of a blood related disorder?

Typical symptoms include fatigue, shortness of breath, Trouble concentrating from lack of oxygenated blood in the brain, Muscle weakness, Fast heartbeat etc.

Which tests/ investigations are generally required by the Hematologist?

The investigations include Full Blood Count Testing, White Blood Cells (WBC) Testing, Red Blood Cells (RBC) Testing, Hemoglobin Testing, Hematocrit and Platelets, Mono Screening, Vitamin B12 Deficiency Testing, and Renal Profiling.

Can a hematologist diagnose cancer?

Hematologic tests aid in the diagnosis of blood diseases such as anemia, certain cancers of the blood and inflammatory diseases, and also help monitor blood loss and infection.

Can blood cancers be cured?

Most of them are curable as it all depends upon the type of blood cancer the patient is suffering from.

Vaidam.com For Medical Procedures

Get a FREE quote

Dr. Jee-Hyun Kim

Hematologist

Consultant
MD

29 years of overall experience

Works at Seoul National University – Bundang Hospital

Book Appointment

WhatsApp Us

About Dr. Jee-Hyun Kim

Dr. Jee-Hyun Kim is a Hematologist-Oncologist in Seongnam, South Korea with experience of over 25+ years.
She received her M.D. degree from Seoul National University in 1995 and later completed her training in internal medicine and hematology-medical oncology at Seoul National University Hospital.
Later, she pursued her Ph.D. degree from Seoul National University College of Medicine.
She became a visiting scientist at Dana Farber Cancer Institute and a visiting professor at Harvard Medical School, where she performed research on novel breast kinases.
Her main research interests include geriatric oncology and early-phase clinical trials of breast cancer, colorectal cancer, and hepatocellular carcinoma.
Dr. Kim is a leader in the area of geriatric oncology in South Korea and is presently running a nationwide cohort analysis for the prediction of chemotherapy toxicity for older cancer patients.

Special Interest

Breast cancer Hepatocellular carcinoma Bone marrow failure syndrome Autologous transplant for multiple myeloma Hemoglobinopathies for thalassemias and sickle cell disease Management of clots and Bleeding problems Immunodeficiency work up